Cargando…
4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
Liver cells isolated from pre‐clinical models are essential tools for studying liver (patho)physiology, and also for screening new therapeutic options. We aimed at developing a new antibody‐free isolation method able to obtain the four main hepatic cell types (hepatocytes, liver sinusoidal endotheli...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349241/ https://www.ncbi.nlm.nih.gov/pubmed/30417530 http://dx.doi.org/10.1111/jcmm.13988 |
_version_ | 1783390242166800384 |
---|---|
author | Fernández‐Iglesias, Anabel Ortega‐Ribera, Martí Guixé‐Muntet, Sergi Gracia‐Sancho, Jordi |
author_facet | Fernández‐Iglesias, Anabel Ortega‐Ribera, Martí Guixé‐Muntet, Sergi Gracia‐Sancho, Jordi |
author_sort | Fernández‐Iglesias, Anabel |
collection | PubMed |
description | Liver cells isolated from pre‐clinical models are essential tools for studying liver (patho)physiology, and also for screening new therapeutic options. We aimed at developing a new antibody‐free isolation method able to obtain the four main hepatic cell types (hepatocytes, liver sinusoidal endothelial cells [LSEC], hepatic macrophages [HMΦ] and hepatic stellate cells [HSC]) from a single rat liver. Control and cirrhotic (CCl(4) and TAA) rat livers (n = 6) were perfused, digested with collagenase and mechanically disaggregated obtaining a multicellular suspension. Hepatocytes were purified by low revolution centrifugations while non‐parenchymal cells were subjected to differential centrifugation. Two different fractions were obtained: HSC and mixed LSEC + HMΦ. Further LSEC and HMΦ enrichment was achieved by selective adherence time to collagen‐coated substrates. Isolated cells showed high viability (80%‐95%) and purity (>95%) and were characterized as functional: hepatocytes synthetized albumin and urea, LSEC maintained endocytic capacity and in vivo fenestrae distribution, HMΦ increased expression of inflammatory markers in response to LPS and HSC were activated upon in vitro culture. The 4 in 1 protocol allows the simultaneous isolation of highly pure and functional hepatic cell sub‐populations from control or cirrhotic single livers without antibody selection. |
format | Online Article Text |
id | pubmed-6349241 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63492412019-02-01 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers Fernández‐Iglesias, Anabel Ortega‐Ribera, Martí Guixé‐Muntet, Sergi Gracia‐Sancho, Jordi J Cell Mol Med Original Articles Liver cells isolated from pre‐clinical models are essential tools for studying liver (patho)physiology, and also for screening new therapeutic options. We aimed at developing a new antibody‐free isolation method able to obtain the four main hepatic cell types (hepatocytes, liver sinusoidal endothelial cells [LSEC], hepatic macrophages [HMΦ] and hepatic stellate cells [HSC]) from a single rat liver. Control and cirrhotic (CCl(4) and TAA) rat livers (n = 6) were perfused, digested with collagenase and mechanically disaggregated obtaining a multicellular suspension. Hepatocytes were purified by low revolution centrifugations while non‐parenchymal cells were subjected to differential centrifugation. Two different fractions were obtained: HSC and mixed LSEC + HMΦ. Further LSEC and HMΦ enrichment was achieved by selective adherence time to collagen‐coated substrates. Isolated cells showed high viability (80%‐95%) and purity (>95%) and were characterized as functional: hepatocytes synthetized albumin and urea, LSEC maintained endocytic capacity and in vivo fenestrae distribution, HMΦ increased expression of inflammatory markers in response to LPS and HSC were activated upon in vitro culture. The 4 in 1 protocol allows the simultaneous isolation of highly pure and functional hepatic cell sub‐populations from control or cirrhotic single livers without antibody selection. John Wiley and Sons Inc. 2018-11-12 2019-02 /pmc/articles/PMC6349241/ /pubmed/30417530 http://dx.doi.org/10.1111/jcmm.13988 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Fernández‐Iglesias, Anabel Ortega‐Ribera, Martí Guixé‐Muntet, Sergi Gracia‐Sancho, Jordi 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
title | 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
title_full | 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
title_fullStr | 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
title_full_unstemmed | 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
title_short | 4 in 1: Antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
title_sort | 4 in 1: antibody‐free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349241/ https://www.ncbi.nlm.nih.gov/pubmed/30417530 http://dx.doi.org/10.1111/jcmm.13988 |
work_keys_str_mv | AT fernandeziglesiasanabel 4in1antibodyfreeprotocolforisolatingthemainhepaticcellsfromhealthyandcirrhoticsingleratlivers AT ortegariberamarti 4in1antibodyfreeprotocolforisolatingthemainhepaticcellsfromhealthyandcirrhoticsingleratlivers AT guixemuntetsergi 4in1antibodyfreeprotocolforisolatingthemainhepaticcellsfromhealthyandcirrhoticsingleratlivers AT graciasanchojordi 4in1antibodyfreeprotocolforisolatingthemainhepaticcellsfromhealthyandcirrhoticsingleratlivers |